Notice of Proposed Rule

DEPARTMENT OF HEALTH
Board of Pharmacy
RULE NO: RULE TITLE
64B16-26.600: Tripartite Continuing Education Committee
PURPOSE AND EFFECT: The Board proposes the rule amendment to clarify the requirements for the Tripartite Continuing Education Committee.
SUMMARY: The rule amendment will clarify the requirements for the Tripartite Continuing Education Committee.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
SPECIFIC AUTHORITY: 465.005, 465.009(5) FS.
LAW IMPLEMENTED: 465.009 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca R. Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3253

THE FULL TEXT OF THE PROPOSED RULE IS:

64B16-26.600 Tripartite Continuing Education Committee.

(1) The Tripartite Continuing Education Committee will be composed of equal representation from the Board of Pharmacy, each College or and School of Pharmacy in the State, and practicing pharmacists within the State. The members of the Committee shall be selected by the Board of Pharmacy and serve for a period of two years. The chairman of the Committee shall be selected by the Chair of the Board.

(2) The Board delegates to the Tripartite Continuing Education Committee the authority to perform the following duties act upon applications submitted pursuant to Rule 64B16-26.601, F.A.C.:, to become a board approved continuing education provider, the approval of individual programs or courses submitted by providers, and

(a) Approve continuing education providers.

(b) Approve continuing education course or program for organizations or individuals that are non-approved providers for the following:

1. General;

2. Initial Consultant Pharmacist Certification;

3. Consultant Recertification;

4.Nuclear Recertification;

5. Medication Errors;

6. HIV/AIDS;

7.Laboratory Tests;

8.Laws and Rules;

9. Misfill Course.

c. Penalties can be from probation to termination of provider status and the Board will be advised of such action.

(3) The Board delegates to the Tripartite Continuing Education Committee the authority to perform auditing and monitoring activities pursuant to Rule 64B16-26.601, F.A.C. The Tripartite Committee shall perform an audit on each approved continuing education provider 90 days prior to the end of the renewal period. The approved provider shall submit the following information for one program:

(a) Title, date and location of the program.

(b) Program Number.

(c) Any Co-sponsors.

(d) Total number of pharmacists attending.

(e) Rosters of attendees with addresses.

(f) Brochures of program announcement.

(g) CV’s of each speaker.

(h) Handouts, Copy of CE Credit statement, educational materials distributed as part of the program.

(i) Summary report of program evaluations.

(4) The Committee shall hold meeting as may be convened at the call of the Chairman of the Committee.

Specific Authority 465.005, 465.009(5) FS. Law Implemented 465.009 FS. History–New 10-18-79, Amended 7-29-81, Formerly 21S-13.01, 21S-13.001, 21S-26.600, 61F10-26.600, 59X-26.600, Amended 10-15-01, 3-10-05,________.


NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy
NAME OF SUPERVISOR OR PERSON WHO APPROVED THE PROPOSED RULE: Board of Pharmacy
DATE PROPOSED RULE APPROVED BY AGENCY HEAD: February 6, 2007
DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAW: April 13, 2007